In progressive stages, the cartilage of the fabella is described as softened and fibrillated or even completely absent.
The current study therefore consists of data rating individual treatment sessions, from a total of19 lay therapists, from three progressive stages: the Internship Stage (Stage 1); the Pilot Stage (Stage 2); and the initial period (Nov 2013 to Feb 2014) of the Trial Stage (Stage 3).
This is in agreement with recent neuropathological evidence for less pronounced inflammation in the normal-appearing WM in the later phases of the progressive stage of the disease, where the inflammatory infiltrates of T, B, and plasmatic cells seem to be reduced when compared with those seen in earlier stages of the disease [Frischer et al., 2009].
During the progressive stage of the disease, the extent of GM demyelination can even exceed that of white matter (WM) demyelination [ 19, 30].
Given the patients included in this study were in the late, progressive stage of the disease, the relationship between tract focal lesion load and diffuse tract pathology may be blurred by a plateau earlier in disease: a phenomenon described in a subset of pathological and clinical studies of multiple sclerosis (Li et al., 2006; Sormani et al., 2009; Caramanos et al., 2012).
The frequency of the deficit syndrome varies depending on the progressive stage of the disease, from about 15% for the first episodes up to 25-30% for the later phases [ 24].
A correlation between axonal injury and inflammation was not only seen in lesions in the progressive stage of the disease, but also in the NAWM.
Demyelination and axonal injury occurs on a background of chronic inflammation in the relapsing as well as in the progressive stage of the disease (Frischer et al., 2009) and close contacts between activated microglia or macrophages and degenerating axons, myelin sheaths and oligodendrocytes have been described (Ferguson et al., 1997; Trapp et al., 1998; Kornek et al., 2000).
> -wrap-foot> Withen the global multiple sclerosis population, patients dying in the course of acute multiple sclerosis showed more accumulation of oxidized lipids and DNA in the lesions as compared with those dying in the progressive stage of the disease.
One of the key results of our study is that in the progressive stage of the disease, active demyelination and neurodegeneration are only seen in patients with pronounced inflammation in the brain.
